Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow CV Sciences, Inc.

Get SEC filing alerts via email and in your feed for CV Sciences, Inc.

CVSI

CV Sciences, Inc.

About CV Sciences, Inc.

CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals, hemp extracts, and plant-based foods. Its core brands include +PlusCBD® for hemp-derived CBD products and Cultured Foods and Lunar Fox for plant-based foods. The company serves retail and online markets in the U.S. and Europe, emphasizing science-backed, high-quality products, with a focus on innovation, regulatory compliance, and strategic acquisitions in the health and food sectors.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from CV Sciences, Inc.

1
1
CV Sciences, Inc. CV Sciences Reports $643,000 Net Loss in Q1 2026, Product Sales Decline 11.4%

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
CV Sciences, Inc. CV Sciences Reports 12.2% Decline in Net Product Sales for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
CV Sciences, Inc. CV Sciences Reports Decline in Revenue and Ongoing Net Loss for Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
CV Sciences, Inc. CV Sciences Reports Revenue Decline and Improved Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
CV Sciences, Inc. CV Sciences Reports Improved Net Loss of $109,000 in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
CV Sciences, Inc. CV Sciences Reports Slight Decline in Sales, Strategic Acquisitions and New Product Launches

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
CV Sciences, Inc. CV Sciences Reports Challenging Financial Performance, Declining Sales and Widened Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments